Increased levels of deleted in malignant brain tumours 1 (DMBT1) in active bacteria‐related appendicitis

Elke Kaemmerer, Ursula Schneider, Christina Klaus, Patrick Sven Plum, Andrea Reinartz, Maximilian Adolf, Marcus Renner, Tim G. A. M. Wolfs, Boris W. Kramer, Norbert Wagner,

Histopathology · 2012 · 15 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

Kaemmerer E, Schneider U, Klaus C, Plum P, Reinartz A, Adolf M, Renner M, Wolfs T G A M, Kramer B W, Wagner N, Mollenhauer J & Gassler N (2012) Histopathology 60, 561–569 Increased levels of deleted in malignant brain tumours 1 (DMBT1) in active bacteria‐related appendicitis Aims: Deleted in malignant brain tumours 1 (DMBT1; gp340) is a secreted glycoprotein which is found in the surface lining epithelia of human small and large intestine. DMBT1 is suggested to play a role in enterocyte differentiation and surface protection from intestinal bacteria. The aim of this study was to elucidate DMBT1 expression in bacteria‐related active intestinal inflammation such as appendicitis. Methods and results: mRNA and protein levels of DMBT1 were analysed in surgical resections of 50 appendices (active inflammation: n = 25). In non‐actively inflamed appendices, inter‐individual differences in basal DMBT1 levels of enterocytes and some non‐epithelial cells were found. In active appendicitis, enterocytic DMBT1 mRNA expression was increased approximately fivefold, which was paralleled by a corresponding increase of cytoplasmic and secreted DMBT1 protein levels. Increased DMBT1 expression was predominant in enterocytes adjacent to erosive lesions or ulcers. Conclusions: Our data demonstrate that bacteria‐related active inflammation results in a sharp increase of DMBT1 levels in enterocytes. These findings substantiate the view that DMBT1 is of functional relevance for host defence and modulation of the course of intestinal bacteria‐related inflammatory responses.

References

19